- ￥400 - 950
- MedChemExpress(MCE)
- 美国
- HY-B0200
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
Cefalexin; Cephacillin
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
15686-71-2
- 规格：
10 mM * 1 mL/500 mg/1 g/5 g
| 规格： | 10 mM * 1 mL | 产品价格： | ￥500.0 |
|---|---|---|---|
| 规格： | 500 mg | 产品价格： | ￥400.0 |
| 规格： | 1 g | 产品价格： | ￥550.0 |
| 规格： | 5 g | 产品价格： | ￥950.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Cephalexin
CAS No. : 15686-71-2
MCE 国际站：Cephalexin
产品活性：Cephalexin (Cefalexin) 是一种口服有效的半合成头孢菌素抗生素 (antibiotic)，具有广泛的抗菌谱。Cephalexin 对多种革兰氏阳性和革兰氏阴性细菌具有抗菌活性。Cephalexin 靶向青霉素结合蛋白 (PBPs)，以抑制细菌细胞壁组装。Cephalexin 可用于肺炎、链球菌性咽喉炎、细菌性心内膜炎等的研究。
研究领域：Anti-infection
作用靶点：Antibiotic | Bacterial
In Vitro: Cephalexin (10 μg/mL) disrupts polymer peptidoglycan (PG) biogenesis by inactivating enzymes called penicillin-binding proteins (PBPs).
Cephalexin inhibits a broad spectrum of grampositive and gram-negative organisms with MIC values of 2, 2, 2, 2, 4, 4.4 and 5.7 μg/mL for Bacillus anthracis, Edwardsiella taFda, Vibrio cholera, Pasteurella multocida, Edwardsiella tarda, Alcaligenes sp and Proteus rettgeri, respectively.
In Vivo: Cephalexin (0-50 mg/kg; p.o.; for 3.5 hours) has antibacterial activity in male Swiss-Webster mice with infected bacterial.
相关产品：Covalent Screening Library Plus | Natural Product-like Compound Library | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Antibacterial Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Antibiotics Library | Drug-Induced Liver Injury (DILI) Compound Library | Rare Diseases Drug Library | Children’s Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Heterocyclic Compound Library | Off-patent Drug Library | Rapamycin | Cycloheximide | Chloroquine | Doxorubicin hydrochloride | Bafilomycin A1 | Dexamethasone | Puromycin dihydrochloride | Dimethyl sulfoxide | Staurosporine | Actinomycin D | G-418 disulfate | Etoposide | 5-Azacytidine | Cyclosporin A | Nigericin sodium salt | Brefeldin A | Estradiol | CCCP | Ionomycin | Resveratrol | Hygromycin B | Tunicamycin | Bleomycin sulfate | Mitomycin C | Everolimus | Doxycycline hyclate | Tacrolimus | Methotrexate | Wortmannin
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Cell cycle analysis of Escherichia coli cells
(ai ) and C+D: From flow cytometry analysis of cells treated with rifampicin and cephalexin (run-out histogram) the proportions of cells that had not initiated replication at the time of drug action (4-origin-cells, streaked
感染时每日2～4g，静脉推注或静脉滴注。 头孢噻啶（cephaloridine）成人0.5～1.0g/次，2～3次/日，肌内注射，每日量不超过4g。 头孢氨苄（cephalexin）成人1～4g/日，分3～4次服。 头孢唑啉（cefazolin）成人500mg/次，2～4次/日，肌内注射或静脉注射，病情严重或耐药菌株，剂量可增大为3～5g/日。儿童剂量为20～100mg/日。 头孢拉定（cefradine）成人1～4g/日，分4次服，对重症者可静脉注射，每日不超8g
atracurium ceftazidime atromid-S celestone atropine cephalexin augmetin cephaloridine azithromycin cephalosporine
技术资料暂无技术资料 索取技术资料
